EMAX CASE STUDIES
PATIENT PATHWAY AND HCP REFERRAL MAPPING FOR A CARDIOLOGY DEVICE IN AUSTRALIA
To help our client identify barriers along both the patient journey and HCP referral pathway that would prevent eligible patients in Australia receiving a cardiology device.
We conducted 15 in-depth interviews with general cardiologists across multiple Australian cities and 16 face-to-face patient interviews.
The in-depth research programme ensured we were able to generate a plethora of insights into questions such as:
What HCPs are patients seeing at different stages of their disease journey?
What is the nature of the patient-HCP interaction, at diagnosis, initiation and later on in their treatment?
What information do HCPs share with their patients and how do patients interpret them?
What is the emotional journey patients go on and how does this affect their treatment choices?
What factors drive treatment recommendations from HCPs and what factors drive patients’ treatment preferences?
What are the reasons why HCPs are not recommending the client’s product in greater numbers?
What specific actions from the client could address these barriers?
We summarised these findings, conclusions and recommendations in an in-depth report and an executive summary and presented the conclusions and recommendations in two sessions to the client’s team.